Tricia Parker, Pharm.D., BCPS

Current Title(s):

  • Assistant Chief, UC Davis Medical Center Inpatient Pharmacy Services
  • Health Sciences Associate Clinical Professor,
    UC San Francisco School of Pharmacy
  • Health Sciences Assistant Clinical Professor,
    UC Davis School of Medicine,
    Division of Pulmonary & Critical Care Medicine

At UC Davis Medical Center since: 1999

Program Director since: 2009

Education:

  • Pharm.D., Creighton University School of Pharmacy and Health Professions, 1999
  • Pharmacy Practice Residency, UC Davis Medical Center, 2000

Professional Biography

Dr. Patricia (Tricia) Parker is the Assistant Chief of Inpatient Pharmacy Services at UC Davis Medical Center. Dr. Parker joined the UCDMC team in 1999 as one of three Pharmacy Practice PGY1 residents, and accepted a career position upon graduation as a Critical Care Staff Pharmacist. In 2003, she was promoted to a Clinical Services Supervisor where she practiced in a split clinical (Critical Care & Nutrition Support) and administrative role for the next five years. Serving as Assistant Chief/Clinical Coordinator since 2008, Dr. Parker is currently responsible for the oversight of planning, implementing and management of clinical pharmacy practice throughout the inpatient setting, assuring efficient and effective clinical services.

Dr. Parker's commitment to hospital pharmacy practice began in 1988 where she worked as a hospital technician for seven years before entering pharmacy school at Creighton University in Omaha, Nebraska in 1995.

In addition to her Assistant Chief/Clinical Coordinator role, she has since obtained faculty positions at both UC San Francisco School of Pharmacy and UC Davis School of Medicine as a Health Sciences Associate and Assistant Professor, respectively. In 2009, Dr. Parker was appointed as the PGY-1 Pharmacy Practice Residency Director for UC Davis Medical Center.

Selected Publications

Delich PC, Siepler JK, Parker, P. Liver Diseases. In: The ASPEN Nutrition Support Core Curriculum. Gottschich MM, Editor. American Society for Parenteral and Enteral Nutrition. Silver Spring, MD pp. 540-557.

Stebbins MR, Cutler TW, and Parker PL. Assessment of Therapy and Medication Therapy Management. In Applied Therapeutics: The Clinical Use of Drugs. 9th edition. Koda-Kimble MA, Young LY, Kradjan WA, Guglielmo BJ, Alldredge BK, Corelli RL, Williams BR eds. Lippincott, Williams & Wilkins: Baltimore, MD, 2008.

Clemens E, Cutler T, Canaria J, Pandya K, and Parker P. Prescriber Compliance with a New Computerized Insulin Guideline for Noncritically Ill Adults. The Annals of Pharmacotherapy 2011; February, Volume 45.

Stebbins MR, Cutler TW, and Parker PL. Assessment of Therapy and Medication Therapy Management. In Applied Therapeutics: The Clinical Use of Drugs. 10th edition. Koda-Kimble MA, Young LY, Kradjan WA, Guglielmo BJ, Alldredge BK, Corelli RL, Williams BR eds. Lippincott, Williams & Wilkins: Baltimore, MD, 2012.

Cutler TW, Parker PL. Medication Errors in the Intensive Care Unit. ICU Management, vol. 9, no. 2, pp. 12-15.

Teresa Kwong, Pharm.D., BCPS, BCACP

Current Title(s):

  • Ambulatory Care Clinical Pharmacist
  • Assistant Professor, UC San Francisco School of Pharmacy
  • Assistant Processor, University of the Pacific

At UCDMC since: 2005

Program Director since: 2008

Education:

  • Pharm.D., University of the Pacific, 2005
  • PGY-1 Pharmacy Practice Residency, UC Davis Medical Center, 2006

Professional Biography

Dr. Teresa Kwong is an Ambulatory Care Pharmacist at UC Davis Medical Center. Her primary clinical practice is in the Anticoagulation Clinic.  She also provides clinical pharmacy services to the Internal Medicine Clinic and Family Practice Clinic.

Dr. Kwong received her doctor of pharmacy degree from University of the Pacific in 2005. Shortly after graduation she began her PGY1 Pharmacy Practice residency at UCDMC. After completion of her residency she  accepted a position in the Anticoagulation Clinic.  Ambulatory care services have continued to evolved and expanded at UCDMC. Dr. Kwong has held roles in the Refill Clinic, Medication Therapy Management Clinic and Hypertension/Hyperlipidemia Clinic. In 2009 Dr. Kwong became director of the PGY1 Ambulatory Care residency program. 

Dr. Kwong is board certified in Ambulatory Care and Pharmacotherapy. In addition she holds volunteer faculty positions as assistant professor with the University of California, San Francisco College of Pharmacy and University of the Pacific College of Pharmacy.

Selected Publications

Batth, S, Branch, J, Giannini, J, Kwong, T, and Wilson, M. Impact of a Clinical Pharmacist’s Interventions on Patient’s Knowledge of Direct Oral Anticoagulants (DOAC). Presented at the Anticoagulation Forum National Conference 2017.

Nguyen, J, Dang, J, and Kwong, T. Evaluation of Safety and Effectiveness of 12 Week Monitoring of Patients Stable on Warfarin at UC Davis Anticoagulation Clinic. Presented at the American College of Clinical Pharmacy Annual Meeting 2013.

Mendoza, P, Kwong, T, Duong, L, and Burton, J. Evaluation of Causes of Supratherapeutic INR at the UCDMC Anticoagulation Clinic. Presented at the American Society of Health System Pharmacists Midyear 2013.

Kwong, T, Shepard, T, Burton, J, Bandy, J, Branch, J, and Giannini, J. Evaluating Time in Therapeutic Range of Warfarin Patients Self Testing With Point of Care Devices. Presented at California Society of Health-System Pharmacists Seminar 2011.

Louie, D, and Kwong, T. Identifying Methods to Improve the Referral Process in Patients Discharged from a University Hospital to an Outpatient Anticoagulation Clinic. Presented at University Health System Consortium meeting at the American Society of Health-System Pharmacists Midyear 2010.

Kwong, T, Sexton, L, Burton, J, Bandy, J, Branch, J, and Giannini, J. Development and Production of a Patient-Specific Warfarin Education Video for a University Teaching Hospital and Outpatient Anticoagulation Clinic. Presented at American Society of Health-System Pharmacists Midyear 2009.

Nguyen, K, Kwong, T, Giannini, J, and Mowers, R. Retrospective Analysis of TZD Utilization Based on FDA Safety Warnings. Presented at University Health System Consortium meeting at the American Society of Health-System Pharmacists Midyear 2008.

Kwong T. (2006). New Treatment Options for Deep Vein Thrombosis and Pulmonary Embolism. UCDMC Drug Perspectives. 1, 3-4.

Kwong, T, Dager, W, and King, J. Evaluation of the Use of Low Molecular Weight Heparins for Venous Thromboembolism Prophylaxis in Trauma Patients. Presented at University Health System Consortium meeting at the American Society of Health-System Pharmacists Midyear 2005.

William Dager, Pharm.D., BCPS, (AQ-Cardiology)

Current Title(s):

  • Pharmacist Specialist, UC Davis Medical Center
  • Clinical Professor of Medicine, UC Davis School of Medicine
  • Clinical Professor of Pharmacy, Touro University College of Pharmacy

At UC Davis Medical Center since: 1985

Program Director since: 2009

Education:

  • Pharm.D., UC San Francisco School of Pharmacy, 1985
  • General Pharmacy Residency, UC Davis Medical Center, 1986
  • Nephrology Pharmaceutical Care Preceptorship, University of Pittsburgh, 1995

Professional Biography

Bill is a board-certified pharmacotherapy specialist with added qualifications in cardiology. He is a clinical specialist at UC Davis Medical Center, where his practice focus is cardiology, cardiovascular surgery and anticoagulation.  He is also involved in pharmacokinetics and management of selected critical care-related situations and mentors residents in nephrology and non-malignant hematology.  He is the director of the PGY-2 residency in cardiology. He currently holds three adjunct academic recognitions as a full professor, and one of 6 pharmacists recognized as a Master in Critical Care Medicine (MCCM).

Bill is a recipient of multiple teaching and mentoring awards, including the ACCP Best Practice award in 2008, the Long teaching award from UCSF and the outstanding mentor award from the ACCP Cardiology PRN. He is a reviewer and/or editorial board member for multiple medical journals, including chair of the Editorial Advisory Board panel on anticoagulation for the Annals of Pharmacotherapy. He is the co-chair for the Society of Critical Care Medicine 2019 Congress and currently serves as a Reagent for the American College of Critical Care Medicine.

Bill has authored approximately 100 peer reviewed articles, over 30 book chapters, and is a co-editor of the ASHP Anticoagulation Therapy Point of Care guide with the second edition published in 2018. He is an active lecturer, both nationally and internationally, and has research interests involving anticoagulation, critical care, cardiovascular disease, and pharmacokinetics/pharmacodynamics.

Selected Publications

Trask A, Gosselin RC, Diaz J, Dager WE. Warfarin initiation and monitoring with clotting factors II, VII and X levels.  The Annals of Pharmacotherapy 2004;38:251-6.

Chan A, Dager WE. Systemic anticoagulant prophylaxis for central catheter associated venous thrombosis in cancer patients. The Annals of Pharmacotherapy 2007;41:635-41.

Heintz BH, Matzke GR, Dager WE.  Antimicrobial Dosing Concepts and Recommendations for Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis. Pharmacotherapy 2009;29:562-77.

Nagle E, Tsu L, Dager WE. Bivalirudin for Anticoagulation during Hypothermic Cardiopulmonary Bypass and Recombinant Factor VIIa for Iatrogenic Coagulopathy. The Annals of Pharmacotherapy 2011;45:e47

Tsu L, Dager WE.  Bivalirudin dosing patterns for renal function including presence of hemodialysis in the management of heparin induced thrombocytopenia. The Annals of Pharmacotherapy 2011;45:1185-92

Heintz BH, Thompson III GR, Dager WE. Clinical Experience with Aminoglycosides in Dialysis-Dependent Patients: Risk Factors for Mortality and Reassessment of Current Dosing Practices. The Annals of Pharmacotherapy 2011;45:1338-45

Tsu LV, Dager WE. Comparison of bivalirudin dosing strategies using total, adjusted, and ideal body weights in obese patients with heparin-induced thrombocytopenia. Pharmacotherapy. 2012;32:20-6.

Tsu LV, Dienes JE, Dager WE. Vitamin K Dosing to Reverse Warfarin Based on INR, Route of Administration, and Home Warfarin Dose in the Acute/Critical Care Setting. Ann Pharmacother. 2012;46:1617-26.

Nagle EL, Dager WE, Duby JJ, Roberts AJ, Kenny LE, Murthy MS, Pretzlaff RK. Bivalirudin in pediatric patients maintained on extracorporeal life support. Pediatr Crit Care Med. 2013;14:e182-8.

Tsu LV, Dager WE. Safety of new oral anticoagulants with dual antiplatelet therapy in patients with acute coronary syndromes. Ann Pharmacother. 2013 Apr;47:573-7.

Pon TK, Dager WE, Roberts AJ, White RH. Subcutaneous enoxaparin for therapeutic anticoagulation in hemodialysis patients. Thromb Res. 2014;133:1023-8.

Dager W, Tsu L, Pon T. Considerations for Systemic Anticoagulation in ESRD. Semin Dial. 2015;28:354-62.

Chen LD, Roberts AJ, Dager WE. Safety and efficacy of starting warfarin after two consecutive platelet count rises in heparin-induced thrombocytopenia. Thromb Res. 2016;144:229-33.

Dager WE, Lee JA. Filtering Out Use of DOACs in Hemodialysis. Ann Pharmacother. 2017;51:511-513.

Steele AP, Lee JA, Dager WE. Incomplete dabigatran reversal with idarucizumab. Clin Toxicol (Phila). 2018;56:216-218.

Walker EA, Dager WE. Bridging with Tirofiban during Oral Antiplatelet Interruption: A Single-Center Case Series Analysis Including Patients on Hemodialysis. Pharmacotherapy. 2017;37:888-892.

Walker EA, Roberts AJ, Louie EL, Dager WE. Bivalirudin Dosing Requirements in Adult Patients on Extracorporeal Life Support with or without Continuous Renal Replacement Therapy. ASAIO J. 2018 Published on line

Jeremiah Duby, Pharm.D., BCPS

Current Title(s):

  • Senior Clinical Pharmacist
  • Assistant Clinical Professor, Touro University College of Pharmacy
  • Assistant Clinical Professor, UC San Francisco School of Pharmacy
  • Assistant Clinical Professor, UC Davis School of Medicine

At UC Davis Medical Center since: 2007

Program Director since: 2010

Education:

  • Pharm.D., Washington State University, 2003
  • PGY-1 Pharmacy Practice Residency, University of Arizona, 2004
  • PGY-2 Critical Care Pharmacy Residency, University of Arizona, 2005

Professional Biography

Dr. Jeremiah Duby is the Senior Critical Care Pharmacist and Specialty Critical Care Residency Program Director for UC Davis Medical Center. He serves as Assistant Clinical Professor for Touro University (TU) College of Pharmacy, UCSF School of Pharmacy, and UC Davis School of Medicine.  His principle practice is in clinical patient care with Trauma Surgery, Burn Surgery, Medical ICU, and Parenteral Nutrition services.  These activities serve as inspiration for his roles in policy and protocol development and research.  Additionally, he provides didactic lectures for TU and UC San Francisco students on acute care topics that include clinical pharmacokinetics, fluid/electrolyte abnormalities, acute pain, sepsis/septic shock, acid-base disorders, skin-soft tissue infections, pneumonia, and clinical toxicology.  Current research interests range from alcohol withdrawal syndrome to diabetic ketoacidosis to acute arrhythmias.

Dr. Duby graduated from Washington State University (2003) and then a completed pharmacy practice residency (PGY-1, 2004, William L. Fritz, MS, FASHP) and critical care residency (PGY-2, 2005, Brian L. Erstad, Pharm.D., FCCM) with an emphasis in infectious diseases and nutrition at the University of Arizona Medical Center (UAMC).  He first served as an infectious diseases pharmacist for Kaiser Permanente (2005 – 2007), helping pilot and establish a successful antimicrobial stewardship service with Stephen M. Parodi, M.D., which later became as model of patient care for the region.

Selected Publications

Nagle E, Dager WE, Duby JJ, Roberts A, Murthy M, Kenny L, Pretzlaff R. Bivalirudin in pediatric patients maintained on extracorporeal life support. Pediatric Critical Care Medicine. (pending press).

Nagle E, Murthy M, Medina M, Floyd K, Love, D, Duby JJ. Nursing clinical discretion and decisions in the provision of pharmacotherapy in the intensive care unit. [abstract/poster]. 42nd Critical Care Congress. San Juan, Puerto Rico: Display and Professor Walk Rounds. January 20, 2012.

Bajorek S, Duby JJ, Heintz S, Heintz H, Cocanour CS. Risk factors, prevalence, course, and complications of atrial fibrillation in critically ill trauma patients. 42nd Critical Care Congress. San Juan, Puerto Rico: Display and Professor Walk Rounds. January 20, 2013.

Murthy M, Nagle E, Parker P, Duby JJ. Doseresponse effect of rescue intravenous dextrose for hypoglycemia in critically ill patients. 42nd Critical Care Congress. San Juan, Puerto Rico: Display and Oral Presentation. January 20, 2013.

Berry A, Cocanour CS, Duby JJ. Management of Alcohol Withdrawal Syndrome (AWS) that Complicates the Course of Critically Ill Patients. [abstract/poster]. 41st Critical Care Congress. Houston, TX: Display and Professor Walk Rounds. February 7, 2012.

Murthy M, Nagle E, Duby JJ, Roach D, Parker P. Dose Response to Rescue Intravenous Dextrose Administration following Hypoglycemic Events with an Insulin Infusion Protocol in Critically Ill Burn Patients. [abstract/poster]. 41st Critical Care Congress. Houston, TX: Display and Professor Walk Rounds. February 7, 2012.

Nagle E, Pretzlaff R, Duby JJ, Roberts JA,Murthy M, Dager WE. A Case Series Describing the Use of Bivalirudin in Pediatric Patients Maintained on Extracorporeal Life Support. [abstract/poster]. 41st Critical Care Congress. Houston, TX. February 4, 2012.

VonMuenster SJ, Cocanour CS, Duby JJ. Prevalence and Course of Atrial Fibrillation (AF) in Critically Ill Trauma Patients. [abstract/poster]. Annual Meeting. Western Surgical Association. Tucson, AZ: Podium Presentation, November 13, 2011.

Matzke GR, Duby JJ. Vancomycin. In: Murphy JE. Clinical Pharmacokinetics. 5th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2011.

Duby JJ, Heintz BH. Clostridium difficile Associated Diarrhea. In: Katz MD, Matthias KR, Chisholm-Burns MA. Pharmacotherapy Principles and Practice Study Guide: A Case-Based Care Plan Approach. New York, NY: McGraw-Hill; 2010: 327 - 329.

Duby JJ. Ketamine: Pharmacology, Controversy, and Role. Clinical Pharmacy and Pharmacology Section Newsletter. Society of Critical Care Medicine. July 2010; 10(2).

Kopp B, Mrsan M, Erstad BL, Duby JJ. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. American Journal of Health-System Pharmacy. 2007; 64: 2483 – 2487.

Duby JJ, Erstad BL, Abarca J, Camamo JM, Huckleberry Y, Bramblett SN. Impact of delayed initiation of erythropoietin in critically ill patients. Blood Disorders. 2007; 7:1.

Duby JJ, Rollins CJ. Survey of nurse administration of phenytoin through enteral feeding tubes concomitantly with enteral nutrition. Poster: ASHP 2007 Summer Meeting and Exhibition. San Francisco, CA. June 25, 2007.

Patanwala AE, Duby JJ, Waters D, Erstad BL. Opioid Conversion in Acute Care. Annals of Pharmacotherapy. 2007; 41(2): 255 – 266.

Monica Donnelley, Pharm.D., BCPS-AQ ID, AAHIVP

Current Title(s):

  • Senior Clinical Pharmacist, Infectious Diseases
  • PGY2 Infectious Diseases Residency Program Director
  • Assistant Professor of Clinical Sciences, UC Davis, School of Medicine
  • Assistant Professor of Clinical Sciences, UC San Francisco School of Pharmacy
  • Assistant Professor of Clinical Sciences, Touro University College of Pharmacy

At UC Davis Medical Center since: 2004

Program Director since: 2016

Education:

  • Pharm.D., Touro University College of Pharmacy, 2010
  • PGY1 Pharmacy Practice Residency, UC Davis Medical Center, 2010-2011
  • PGY2 Infectious Diseases Residency, UC Davis Medical Center 2011-2012

Professional Biography

Dr. Monica Donnelley is board certified in pharmacotherapy with added qualifications in infectious diseases. She is a Senior Pharmacist at UC Davis Medical Center. Dr. Donnelley began her pharmacy career at UCDMC in 2004 as an inpatient pharmacy technician during her undergraduate education. Graduating from pharmacy school in 2010, she was the recipient of the Mylan Institute Pharmacy Excellency Award and went on to complete a PGY1 Pharmacy Practice Residency and PGY2 Infectious Diseases Residency at UCDMC.  Following completion of her ID PGY2 she accepted a position with UCDMC, focusing on infectious diseases and medication safety. Concurrently she also began teaching at Touro University (TU), College of Pharmacy in the Clinical Sciences track and obtained a volunteer faculty position as an assistant professor with the University of San Francisco, College of Pharmacy. In 2013 she was awarded Professor of the Year in Clinical Sciences at TU. After practicing as a pharmacist for five years Dr. Donnelley was promoted to Senior Pharmacist and in 2016 she assumed directorship of the long standing PGY2 infectious diseases residency program upon the retirement of her PGY2 residency director Cinda Christensen. Dr. Donnelley was awarded the UC Davis Pharmacy Residency Program Preceptor of the Year award for the 2016-2017 class.
Dr. Donnelley’s clinical practice focuses on the transition of inpatients to outpatient parenteral antimicrobial therapy (OPAT) and the optimizations of their therapy plans. Other areas of research include reduction of C. difficile infection rates through refinement of antimicrobial stewardship interventions. Her program strives to prepare PGY2 graduates for careers as infectious diseases pharmacy specialists and/or academia.

Selected Publications

Donnelley, MA, Zhu, ES, Thompson, GR III. Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections. Infection and Drug Resistance. Review  2016

Bui, C, Zhu, E., Donnelley, MA, Wilson, M., Morita, M., Cohen, SH., Brown, J. Antimicrobial Stewardship Programs that Target Only High-Cost, Broad-Spectrum Antimicrobials Miss Opportunities to Reduce Clostridium difficile Infections. American Journal of Infection Control. 2016
    
Heintz, B, Donnelley, M, Tasaka, C, Duby, J. Vancomycin. Clinical Pharmacokinetics 6th Edition. Book Chapter 22. 2016.

Donnelley, M, Heintz, B, Duby, J, Clostridium difficile infection. Pharmacotherapy Principles and Practice Study Guide: A Case Based Care. Book Chapter 4th edition. 2016.

Donnelley, M, Duby, J, Cocanour, C. Safety and Efficacy of Fidaxomicin in Patients with Clostridium Difficile Infection. Clinical Medicine Insights: Therapeutics. 2013:5 75-79. Review Paper. DOI: 10.4137/CMT.S7279.

Donnelley, M, Christensen, C, Heintz, B. Outcomes in patients discharged from an academic medical center on outpatient parenteral antimicrobial therapy (OPAT) following interventions by a multidisciplinary OPAT team. [poster] Presented at National Meeting, Infectious Diseases Society of America October 2012, San Diego, CA

Donnelley, M, Kim, J, Christensen, C, Wiedeman. Benefits of a pediatric antimicrobial stewardship program at a large academic medical center. [poster]. Making a difference in infectious diseases (MAD-ID), Orlando, Fl, 2012

Andrea Iannucci, Pharm.D., BCOP

Current Title(s):

  • Assistant Chief, Oncology and Investigational Drug Services
  • Oncology Pharmacy Specialist, UC Davis Medical Center Pharmacy Services
  • Health Sciences Clinical Professor, UC San Francisco School of Pharmacy and UC Davis School of Medicine

At UC Davis Medical Center since: 2002

Program Director since: 2004

Education:

  • Pharm.D., UC San Francisco School of Pharmacy
  • PGY-1 Pharmacy Residency, UC San Francisco
  • PGY-2 Oncology Residency, MD Anderson Cancer Center

Professional Biography

Dr. Andrea Iannucci has practiced in oncology pharmacy for 25 years. In the past, she has also served as a full-time faculty member at the University of Colorado School of Pharmacy and as the Director of Clinical Services for the Rocky Mountain Cancer Centers.  Andrea joined the UC Davis Pharmacy team in 2002 as a Senior Oncology Pharmacist.  She started the PGY2 Oncology Residency Program in 2004 and has graduated nearly 20 oncology pharmacists from the program.  Andrea has served as an IRB member with the UC Davis Medical Center IRB. She currently serves as a member of the UC Davis Cancer Center Scientific Review Committee. Andrea is the co-chair of the Oncology Sub-Committee of the UC Davis Pharmacy and Therapeutics Committee and she oversees the operations of oncology pharmacy and investigational services at UC Davis.   Andrea has also been involved in the Board of Pharmaceutical Specialties (BPS) Oncology Specialty Council and most recently served on the BPS Board of Directors, where she has served as the BPS chair. 

Selected Publications

Iannucci A, Reed Jeanne, Bell T.  “Chapter 21: Cancer and Chemotherapy” in Pharmacology Essentials for Technicians, 2011; Paradigm Publishing, Inc. (St. Paul, MN).

Rao, KV, Iannucci AA, Jabbour E.  Current and Future Clinical Strategies in the Management of Chronic Myeloid Leukemia.  Pharmacotherapy 2010;30(9 Pt 2):77S–101S.

Superfin D, Iannucci AA, Davies A. Commentary: Oncologic Drugs in Organ dysfunction: A Summary. The Oncologist, 2007;12;1070-1083.

Iannucci A and Chan, A.  “Management and Treatment of Hematologic Toxicities” in Unit 3, Supportive Care in Mosby’s Oncology Drug Reference, 2007; Mosby Elsevier (St. Louis, MO).

Stull DM, Iannucci A, Bertin R.  Board-Certified Oncology Pharmacists: Partners in the Multidisciplinary Care of Cancer Patients. Community Oncology, 2006;3(5):284-286.

Balmer CM, Valley AW, Iannucci A.  Cancer Treatment and Chemotherapy in Pharmacotherapy: A Pathophysiologic Approach, 6th Edition.  DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors, 2005, McGraw-Hill Companies, Inc.

Chan A, Iannucci A, Dager WE. Systemic Anticoagulant Prophylaxis for Central Catheter-associated Venous Thrombosis in Cancer Patients.  Annals of Pharmacotherapy 2007, 41:635-641.

Gibbs P, Iannucci A, Allen J, O'Driscoll M, McDowell K, Williams P, Rosse P, Murphy J, Gonzalez R.  A Phase II Study of Biochemotherapy for the Treatment of Metastatic Malignant Melanoma.  Melanoma Research, 2000; 10: 171-179.

Mark Holtsman, Pharm.D.

Current Title(s):

  • Senior Clinical Pharmacist, Pain Management Service
  • Co-Director, Inpatient Pain Service
  • Clinical Professor, Anesthesiology and Pain Medicine,
    UC Davis School of Medicine

At UCDMC since: 1988

Program Director since: 2009

Education:

  • Pharm.D., University of the Pacific
  • Residency in Clinical Pharmacy, UC San Francisco

Professional Biography

As Co-Director of the Inpatient Pain Service at UC Davis Medical Center and as the Clinical Professor of Anesthesiology and Pain Medicine at the University ofCalifornia Davis School of Medicine, Dr. Holtsman constantly works to provide education in Pain Management to pharmacists, physicians, and nurses. He hasworked with the Pain Management Service at UC Davis Medical Center since 1991 and has been the Pain Management Service Pharmacist since 1996, where he developed a Pain Management Rotation for pharmacy students and residents. In 2004, he became Co-Director of the Inpatient Pain Service with responsibility for education of Anesthesia Pain Fellows, Residents, and Medical Students in Anesthesiology and Pain Medicine at UC Davis Medical Center. He lectures all over the Northwest on Pain Management and currently works as a faculty member in Anesthesiology and Pain Medicine at UC Davis Medical Center. He recentlyspent one month as a Visiting Professor in Japan at Kobe Gakuin University and taught Pain and Palliative Care to pharmacy students. His major research interests include investigating barriers to opioid prescribing, pharmacist knowledge and attitudes about controlled substance prescribing laws, and breakthrough pain treatment in cancer patients. He has worked on projects to improve PCA safety, PCA documentation, fentanyl transdermal system use, and methadone use by helping to develop tools within the health system’s electronic medical record, working to educate staff on importance of documentation, and auditing changes before and after implementation to assess effectiveness of interventions.

Selected Publications

Holtsman M, Wilsey BL, Opioids Used for Mild to Moderate Pain. In: Benzon HT, Raja SN, Liu SS, Fishman SM, Cohen SP eds.Essentials of Pain Medicine and Regional Anesthesia. Philadelphia: Elsevier Churchill Livingstone; 2011: 97-100.

Mahajan G, Sheth S,Holtsman M, Major Opioids in Pain Management. In: Benzon HT, Raja SN, Liu SS, Fishman SM, Cohen SP eds.Essentials of Pain Medicine and Regional Anesthesia. Philadelphia: Elsevier Churchill Livingstone; 2011: 85-96.

Improving Adherence to Fentanyl Transdermal System Black Box Warnings by Adding Questions to Physician Order Entry. Aaron J. Prince, PharmD, Ashley Trask, PharmD, Patricia Parker, Mark L. Holtsman, PharmD Abstract 149 Pain Med. 2011 Mar;12(3):486.

Opioid Dose Evaluation for Breakthrough Pain and Its Proportionality to the Total Opioid Dose in Cancer Patients with Chronic Opioid Use. Nguyen M, and Holtsman M. Abstract 196 Pain Med. 2009 Jan;10(1):247.

Commentary on Dr. Heit and Dr. Gilson’s letter to the Drug Enforcement Administration. Does your Pharmacist Interpret a New Federal Standard in a Manner that Can Make your Patient Suffer in Pain? Holtsman M. Pain Med. 2008 Oct;9(7):927.

Fentanyl buccal tablets effective for pediatric patient with episodic pain secondary to ulcerative coloitis. Holtsman ML, Wania-Galicia L, and Williamson D. J Pain 9(4) Supp 1 April 2008 Page 39 Abstract 253 Presented at American Pain Society Annual Meeting May 2008.

Ending triplicate prescription use in California: The effect on prescribing patterns of controlled substances, Cello R, Holtsman M, and Mowers R. J Pain, April 2007: 8:4:S86 Abstract.

Evaluating the effectiveness of a pharmacist-managed pain consult service in postoperativeknee replacement patients. Yacoub, C, Liang L, Ryu J, Thongsinthusak T, andHoltsman M. Abstract 290, ACCP Annual Meeting, St. Louis, Missouri October 2006.

Holtsman M, Fishman SM. Opioid Receptors. In: Benzon HT, Raja SN, Molloy RE, Liu SS, Fishman SM eds.

Essentials of Pain Medicine and Regional Anesthesia. Philadelphia: Elsevier Churchill Livingstone; 2005: 87-93.

Fishman SM, Condon J, Holtsman ML. Common Opioid-Related Side Effects. In: Warfield CA, Bajwa ZH eds. PRINCIPLES AND PRACTICE OF PAIN MEDICINE. New York: McGraw-Hill; 2004: 612-615.

Brent Hall, Pharm.D., BCPPS

Current Title(s):

  • Senior Pharmacist, Pediatrics
  • Assistant Clinical Professor, UCSF School of Pharmacy

At UC Davis Medical Center since: 2014

Program Director since: 2015

Education:

  • PGY 1 Northwestern Memorial Hospital, Chicago, IL, July 1999-June 2000
  • Pharm.D., Purdue University School of Pharmacy, 1999
  • BS Biology/Physiology, Purdue University School of Science, 1998

Professional Biography

Brent Hall is currently a Senior Pharmacist in Pediatrics at the UC Davis Medical Center.  After completion of his residency, Brent accepted a position at University Medical Center in Tucson, Arizona.  This institution served as the teaching hospital for the University of Arizona Schools of Pharmacy, Medicine, Nursing and Public Health.  Brent first served as a staff pharmacist in pediatrics before advancing to the position of  Clinical Coordinator for Pediatric Pharmacy.  Over the 14 years that he spent in Arizona he was able to grow his service from 1 FTE to 4 FTEs with an expanding precepting program for University of Arizona pharmacy students as well as helping to lay the groundwork for the development of a PGY 2 Pediatric Pharmacy Residency Program.  Brent was also very active in the Schools of Pharmacy, Medicine and Nursing providing didactic lectures, precepting and course coordination.  In 2014, Brent moved his practice to Sacramento, California to help with the establishment of the PGY 2 Pediatric Pharmacy Residency Program and expansion of clinical services.  Brent is actively involved with programs at UC Davis Children’s Hospital which include Chairman of the Too Keep Open Protocol Development Team, Co-Chair of the Department of Pharmacy Committee on Education, Pediatric Heart Center Group for protocol development, UC Davis Pediatric Pain Team, Pediatric Medication Error Committee and PICU Committee Representative.  Nationally he is actively involved in ACCP, PPAG and has worked on the A-F Bundle Project with SCCM as well as Opioid Stewardship programs with Delphi.   Brent’s areas of interest include critical care medicine, sedation/delirium management and pain control.

Selected Publications

“QTc prolongation in hospitalized pediatric patients receiving methadone” Schwinghammer, A; Wilson, M; Hall, B.  Ped Crit Care Med – accepted, publication date pending

“Dexmedetomidine Use in Critically Ill Children with Acute Respiratory Failure” Grant, M; Schneider, J; Asaro, L; Dodson, B; Hall, B; Simone, S; Cowl, A; Munkwitz, M; Wypij, D; Curely, M. Pediatric Crit Care Med, 2016 Dec; 17(12):1131-41.

“Neonatal Extravasation: An Overview and Algorithm for Evidence-Based Treatment” Beall, V; Hall, B; Mulholland, J.; Gephart, S. Newborn and Infant Nursing Reviews Journal, Vol 13, Number 4, December 2013, pp189-95.

Current Research Projects

“Randomized, Placebo Controlled, Trial to Evaluate the Use of Gabapentin in Pediatric Cardiothoracic Surgery Patients to Reduce Opioid Requirements Post Operatively”  Hall, B, Raff, G – Grant application under review

“A Non Inferiority Trial Comparing TKO Rates on Need for Line Replacement in Pediatric Patients” Bhavsar, V; McLearan, H; Mooney, P; Signoff, J; Hall, B – Data Collection is ongoing, expected data analysis to start 2020

“Assessment of pain/sedation protocol for mechanically ventilated patient’s in UC Davis Childrens’ Medical Center PICU”, Data collection ongoing, expected data analysis to start 2020

“A Randomized, Placebo Controlled, Double Dummy Trial to Evaluate a Single Preoperative Oral Acetaminophen Dose vs IV on Postoperative Opioid Use in Patient’s Undergoing Tonsillectomy”, Lammers, C; Schwinghammer, A; Hall, B; Applegate, R. – Enrollment ongoing with expected data analysis to start January 2019

Julianna Burton, Pharm.D., BCPS, FCSHP

Current Title(s):

  • Assistant Chief of Pharmacy
  • Associate Professor, UC San Francisco School of Pharmacy
  • Assistant Professor, University of the Pacific

At UCDMC since: 2004

Program Director since: 2012

Education:

  • PGY-1 Pharmacy Residency, St. Joseph’s Medical Center, 2000
  • Pharm.D., University of the Pacific, 1999

Professional Biography

Dr. Julianna Burton completed her Bachelors of Science in Medicinal Chemistry in 1998 from the University of the Pacific. She continued on to complete her PharmD at the University of the Pacific in 1999. Dr. Burton finished a PGY1 pharmacy residency at St. Joseph’s Medical Center in Stockton, California.

In 2000, Dr. Burton began working at Kaiser Permanente in Sacramento as a Clinical Pharmacist. Her position crossed lines between inpatient and outpatient with satellite staffing and clinic staffing in the same position. Dr. Burton focused her efforts on expanding pharmacy services in the clinics by providing patients with appointments for hypertension and hyperlipidemia.

In 2004 Dr. Burton began her work at UC Davis Medical Center. Her position as the ambulatory care supervisor allowed her to further expand the role of the pharmacist. She began a pharmacy Refill clinic, Cardiology clinic and an MTM clinic, in addition to supervising an anticoagulation clinic.

She continues to advance the practice of pharmacy and in 2013 began supervision of a Transition of Care team to improve the continuity of care for patients being discharged from the hospital.

Dr. Burton is very active in her professional organizations, having sat on the Board of Directors for the California Society of Health System’s Pharmacists as well as many roles from Secretary to President for her local chapter of Sacramento Valley, as well as NCCCP President.

Selected Publications

Implementing and Providing Transitions of Care between Health Care Settings. Powerpak, April 2016

SB493: Making the Case for Other Providers. California Pharmacist. Winter 2015. Pp 17-20, Oct 2015

Implementing a Successful Transitions Program while Avoiding Commong Pitfalls. CJHP. Vol 27. No 1. Pp 7-14, Jan/Feb 2015

Burton JL, Jeong, E, Stebbins, M, Chen, S. CSHP’s MTM Resource Guide, February 2012

Contributor Joint Commission’s Anticoagulation Resource Handbook. Ladan Cockshut, writer. Janet Pimentel, Senior Editor, April 2008

Co-created “Warfarin: What is it and how does it affect me” Video. Available at Kendall-Hunt.com, April 2008

Note to applicants: Please direct application materials (via PhORCAS) to the respective program director above.

Please direct questions to: hs-rxresidency@ucdavis.edu